References and Notes
<A NAME="RD15606ST-1A">1a</A>
Lehmann J.
Hutchison AJ.
McPherson SE.
Mondadori C.
Schmutz M.
Sinton CM.
Tsai C.
Murphy DE.
Steel DJ.
Williams M.
Cheney DL.
Wood PL.
J. Pharmacol. Exp. Ther.
1988,
246:
65
<A NAME="RD15606ST-1B">1b</A>
Ornstein PL.
Schaus JM.
Chambers JW.
Huser DL.
Leander JD.
Wong DT.
Paschal JW.
Jones ND.
Deeter JB.
J. Med. Chem.
1989,
32:
827
<A NAME="RD15606ST-1C">1c</A>
Miur KW.
Lees FR.
Stroke
1995,
26:
503
<A NAME="RD15606ST-2">2</A>
Hutchison AJ.
Williams M.
Angst C.
de Jesus R.
Blanchard L.
Jackson RH.
Wilusz EJ.
Murphy DE.
Bernard PS.
Schneider J.
Campbell T.
Guida W.
Sills MA.
J. Med. Chem.
1989,
32:
2171
<A NAME="RD15606ST-3">3</A>
Baudy RB.
Fletcher H.
Yardley JP.
Zaleska MM.
Bramlett DR.
Tasse RP.
Kowal DM.
Katz AH.
Moyer JA.
Abou-Gharbia M.
J. Med. Chem.
2001,
44:
1516 ; and references cited therein
<A NAME="RD15606ST-4A">4a</A>
Davis SM.
Lees KR.
Albers GW.
Diener HC.
Markabi S.
Karlsson G.
Norris J.
Stroke
2000,
31:
347
<A NAME="RD15606ST-4B">4b</A>
Ikonomidou C.
Turski C.
Lancet Neurol.
2002,
1:
383
<A NAME="RD15606ST-4C">4c</A>
Hoyte L.
Barber PA.
Buchan AM.
Hill MD.
Curr. Mol. Med.
2004,
4:
131
<A NAME="RD15606ST-5">5</A>
Skiles JW.
Giannousis PP.
Fales KR.
Bioorg. Med. Chem. Lett.
1996,
6:
963
<A NAME="RD15606ST-6">6</A>
Badorrey R.
Cativiela C.
Díaz-de-Villegas MD.
Gálvez JA.
Tetrahedron
1999,
55:
7601
<A NAME="RD15606ST-7">7</A>
Blanchette MA.
Choy W.
Davis JT.
Essenfield AP.
Masamune S.
Roush WR.
Sakai T.
Tetrahedron Lett.
1984,
25:
2183
<A NAME="RD15606ST-8">8</A>
In the absence of LiCl the HWE olefination reaction using DBU as base did not take
place.
<A NAME="RD15606ST-9">9</A>
(
E
/
Z
)-(
R
)-2-[(
S
)-1,2-Dibenzyloxyethyl]-4-diethylphos-phonomethylene-1-[(S)-1-phenylethyl]piperidine
(5). A 2 M solution of LDA in heptane-THF-ethylbenzene (1.75 mL, 3.5 mmol) was added
to a solution of tetraethyl methylenediphosphonate (0.86 g, 3.0 mmol) in anhydrous
THF (10 mL) at r.t. under argon and the mixture was stirred for 10 min. A solution
of compound 4 (0.44 g, 1.0 mmol) in anhydrous THF (20 mL) was added and the resulting mixture was
stirred at r.t. for 23 h (until conversion was complete as monitored by TLC). The
reaction was quenched with H2O (30 mL) and extracted with CH2Cl2 (3 × 50 mL). The combined organic extracts were dried over anhydrous MgSO4, filtered, evaporated under reduced pressure and subsequently chromatographed on
silica gel (EtOAc) to yield compound 5 (520 mg, 90%) as an 84:16 mixture of E/Z diastereoisomers, respectively. Data for E diastereoisomer: IR (neat): 1631, 1241 cm-1; 1H NMR (400 MHz, CDCl3): δ = 1.21 (d, J = 6.8 Hz, 3 H), 1.24 (t, J = 7.7 Hz, 3 H), 1.24 (t, J = 7.7 Hz, 3 H), 2.11 (dd, J = 13.4, 8.0 Hz, 1 H), 2.27 (ddd, J = 12.2, 7.3, 3.1 Hz, 1 H), 2.37 (ddd, J = 11.8, 3.3, 3.3 Hz, 1 H), 2.56-2.65 (m, 2 H), 2.70-2.78 (m, 1 H), 2.99-3.05 (m,
1 H), 3.60 (dd, J = 10.6, 6.5 Hz, 1 H), 3.90 (dd, J = 10.6, 1.8 Hz, 1 H), 3.89-3.96 (m, 1 H), 3.98 (q, J = 7.7 Hz, 4 H), 4.06 (q, J = 6.8 Hz, 1 H), 4.49 (d, J = 12.1 Hz, 1 H), 4.54 (d, J = 12.1 Hz, 1 H), 4.62 (d, J = 11.9 Hz, 1 H), 4.74 (d, J = 11.9 Hz, 1 H), 5.30 (d, J = 19.4 Hz, 1 H), 7.15-7.38 (m, 15 H); 13C NMR (100 MHz, CDCl3): δ = 13.2, 16.4 (d, J = 6.5 Hz), 31.0 (d, J = 6.9 Hz), 37.9 (d, J = 23.6 Hz), 44.6, 56.5, 59.0, 61.2 (d, J = 2.1 Hz), 61.2 (d, J = 2.1 Hz), 70.9, 72.7, 73.5, 78.1, 110.1 (d, J = 186.7 Hz), 126.6, 127.4, 127.5, 127.6, 127.7, 127.8, 128.1, 128.3, 128.4, 138.2,
138.8, 144.5, 163.2 (d, J = 6.9 Hz); 31P NMR (162 MHz, CDCl3): δ = 17.9; HRMS (ESI+): m/z [M + H+] calcd for C34H45NO5P: 578.3030; found: 578.3034.
<A NAME="RD15606ST-10">10</A>
Following complete assignment of the 1H resonances by 2D NMR studies (COSY, HSQC), the E/Z configuration of the exocyclic double bond was unequivocally determined by a series
of selective 1D gradient-enhanced nuclear Overhauser enhancement (ge-1D NOESY) experiments.
3
J
C-P values measured in 13C NMR spectra provided additional support to the assignment. Diastereomeric ratios
were determined by 1H and 31P analyses of the crude reaction mixture.
<A NAME="RD15606ST-11">11</A>
(2
R
,4
S
)-2-[(
S
)-1,2-Dibenzyloxyethyl]-4-diethylphos-phonomethyl-1-[(S)-1-phenylethyl]piperidine
(6). To an E/Z mixture (84:16) of compound 5 (0.58 g, 1 mmol) dissolved in absolute EtOH (18 mL) was added PtO2 (0.06 g, 0.25 mmol) and the mixture was hydrogenated under an atmosphere of H2 with shaking at r.t. for 8 h. The reaction mixture was filtered through Celite® 545 and concentrated in vacuo to afford an 85:15 mixture of 6 and 9, respectively. Purification of the residue by silica gel column chromatog-raphy (EtOAc
® EtOAc-EtOH, 4:1) gave 9 (77 mg, 13%) and 6 (435 mg, 74%) as oils. Data for 6: [α]D
25 +13.8 (c 1.07, CHCl3); IR (neat): 1247 cm-1; 1H NMR (400 MHz, CDCl3): δ = 0.80-2.65 (m, 2 H), 1.16 (d, J = 6.8 Hz, 3 H), 1.25 (t, J = 6.3 Hz, 3 H), 1.25 (t, J = 6.0 Hz, 3 H), 1.51-1.73 (m, 4 H), 2.04 (ddd, J = 11.6, 11.6, 1.9 Hz, 1 H), 2.17 (dd, J = 12.6, 2.1 Hz, 1 H), 2.34 (ddd, J = 11.6, 3.0, 3.0 Hz, 1 H), 2.74 (ddd, J = 11.1, 4.0, 2.1 Hz, 1 H), 3.65 (dd, J = 10.6, 7.9 Hz, 1 H), 3.96-4.06 (m, 5 H), 4.07-4.14 (m, 2 H), 4.49 (d, J = 12.2 Hz, 1 H), 4.59 (d, J = 12.2 Hz, 1 H), 4.70 (d, J = 11.9 Hz, 1 H), 4.80 (d, J = 11.9 Hz, 1 H), 7.15-7.41 (m, 15 H); 13C NMR (100 MHz, CDCl3): δ = 6.7, 15.4 (d, J = 6.0 Hz), 29.9 (d, J = 239.3 Hz), 30.7 (d, J = 4.0 Hz), 32.5 (d, J = 12.3 Hz), 33.3 (d, J = 13.6 Hz), 43.8, 52.7, 58.0, 60.2 (d, J = 6.6 Hz), 60.4 (d, J = 6.5 Hz,), 70.4, 71.7, 72.4, 76.6, 125.3, 126.4, 126.5, 126.5, 126.5, 126.7, 126.9,
127.3, 127.4, 137.4, 138.0, 142.6; 31P NMR (162 MHz, CDCl3): δ = 31.4; HRMS (ESI+): m/z [M + H+] calcd for C34H47NO5P: 580.3186; found: 580.3192.
<A NAME="RD15606ST-12">12</A>
(2
R
,4
S
)-1-
tert
-Butoxycarbonyl-4-diethylphosphono-methyl-2-[(
S
)-1,2-dihydroxyethyl]piperidine (7). Chromatography eluent: (EtOAc ® EtOAc-EtOH, 4:1); yield: 79%; oil, [α]D
25 +44.4 (c 0.59, CHCl3); IR (neat): 3404, 1684, 1249 cm-1; 1H NMR (400 MHz, CDCl3): δ = 1.17-1.26 (m, 1 H), 1.31 (t, J = 7.1 Hz, 6 H), 1.42-1.48 (m, 1 H), 1.45 (s, 9 H), 1.65-1.82 (m, 2 H), 1.82-1.89
(m, 1 H), 1.91-2.02 (m, 1 H), 1.98-2.10 (m, 1 H), 3.29-3.38 (m, 1 H), 3.45-3.52 (m,
1 H), 3.53 (dd, J = 11.8, 6.1 Hz, 1 H), 3.58 (dd, J = 11.8, 5.4 Hz, 1 H), 3.66-3.72 (m, 1 H), 3.78-3.85 (m, 1 H), 4.08 (q, J = 7.1 Hz, 4 H); 13C NMR (100 MHz, CDCl3): δ = 16.4 (d, J = 5.9 Hz), 27.7 (d, J = 4.1 Hz), 28.3, 30.8 (d, J = 10.1 Hz), 32.1 (d, J = 12.1 Hz), 32.4 (d, J = 139.8 Hz), 41.5, 56.6, 61.5 (d, J = 6.0 Hz), 63.9, 74.1, 80.7, 158.3; 31P NMR (162 MHz, CDCl3): δ = 30.3; HRMS (ESI+): m/z [M + Na+] calcd for C17H34NO7PNa: 418.1965; found: 418.1973.
<A NAME="RD15606ST-13">13</A>
Representative Procedure for N- and O-Debenzylation: To a solution of the corresponding 2-[(S)-1,2-dibenzyl-oxyethyl]-4-diethylphosphonomethyl-1-[(S)-1-phenyl-ethyl]piperidine (0.44 g, 0.75 mmol) in absolute ethanol (12 mL) were added successively Boc2O (0.65 g, 3.0 mmol) and Pd(OH)2/C (20%, 0.22 g) and the mixture was stirred at r.t. under an atmosphere of H2 for 48 h. After completion of the reaction, the mixture was filtered through Celite® 545 and concentrated in vacuo. The residue was purified by silica gel flash column
chromatography.
<A NAME="RD15606ST-14">14</A>
Representative Procedure for Oxidative Cleavage: NaIO4 (0.57 g, 2.37 mmol) was added to a stirred solution of the corresponding 1-tert-butoxycarbonyl-4-diethylphosphono-methyl-2-[(S)-1,2-dihydroxyethyl]piperidine (0.25 g, 0.59 mmol) in MeCN-CCl4-H2O (2:2:3, 20 mL). After being vigorously stirred for 5 min, anhydrous RuCl3 (0.006 g, 0.030 mmol) was added to the mixture and stirring was continued for 2 h.
The reaction mixture was extracted with CH2Cl2 (3 × 20 mL) and the combined organic layers were dried over anhydrous MgSO4 and the solvent evaporated in vacuo. The residue was purified by flash chromatography
on silica gel (eluent: EtOAc-EtOH, 4:1).
<A NAME="RD15606ST-15">15</A>
(2
R
,4
S
)-1-
tert
-Butoxycarbonyl-4-diethylphosphono-methylpipecolic Acid (8).Yield 76%; oil, [α]D
25 +12.5 (c 1.00, CHCl3); IR (neat) 3600-2300, 1726, 1692, 1247 cm-1; 1H NMR (400 MHz, CDCl3): δ = 1.27 (t, J = 7.0 Hz, 3 H), 1.28 (t, J = 7.1 Hz, 3 H), 1.40 (s, 9 H), 1.54-1.63 (m, 1 H), 1.69-1.77 (m, 1 H), 1.76-1.92
(m, 2 H), 1.91-2.01 (m, 1 H), 2.03-2.19 (m, 2 H), 3.31 (br dd, J = 10.4, 10.4 Hz, 1 H), 3.58-3.67 (m, 1 H), 4.01-4.12 (m, 4 H), 4.35-4.44 (m, 1 H),
8.54-9.00 (br s, 1 H); 13C NMR (100 MHz, CDCl3): δ = 16.2 (d, J = 5.9 Hz), 26.0 (d, J = 4.4 Hz), 28.3, 28.7 (d, J = 173.1 Hz), 29.3 (d, J = 6.9 Hz), 32.2 (d, J = 3.1 Hz), 37.9, 53.0, 61.9 (d, J = 6.7 Hz), 62.0 (d, J = 6.6 Hz), 80.2, 155.8, 174.9; 31P NMR (162 MHz, CDCl3): δ = 31.5; HRMS (ESI+): m/z [M + Na+] calcd for C16H30NO7PNa: 402.1652; found: 402.1647.
<A NAME="RD15606ST-16">16</A>
Representative Procedure for Total Hydrolysis: A mixture of the corresponding 1-tert-butoxycarbonyl-4-diethylphosphonomethylpipecolic acid (0.16 g, 0.4 mmol) and 6 N aq HCl (9 mL) was heated under reflux for 16 h, after which
time the mixture was concentrated in vacuo. The resulting residue was dissolved in
70% aq EtOH (3 mL) and propylene oxide (0.4 mL) was added. After stirring for 10 min
at r.t. the reaction mixture was washed with CH2Cl2 (15 mL) and the aqueous layer was evaporated in vacuo. The residue was purified by silica gel flash chromatography (MeCN-H2O, 4:1® MeCN-H2O, 1:1) and lyophilized.
<A NAME="RD15606ST-17">17</A>
(2
R
,4
S
)-4-Phosphonomethylpipecolic Acid (1). Yield 69%; white solid, mp = 292-294 °C; [α]D
25 -3.54 (c 1.00, H2O); IR (KBr): 3700-2200, 3399, 1732, 1282 cm-1; 1H NMR (400 MHz, D2O): δ = 1.35-1.50 (m, 1 H), 1.42 (ddd, J = 12.9, 12.9, 12.9 Hz, 1 H), 1.64 (ddd, J = 17.6, 14.5, 6.8 Hz, 1 H), 1.69 (ddd, J = 17.6, 14.5, 5.7 Hz, 1 H), 1.96-2.10 (m, 1 H), 2.19 (br d, J = 14.4 Hz, 1 H), 2.44 (br dd, J = 12.9, 1.7 Hz, 1 H), 3.05 (ddd, J = 12.9, 12.9, 2.9 Hz, 1 H), 3.97 (ddd, J = 12.9, 3.7, 1.8 Hz, 1 H), 3.64 (dd, J = 12.9, 3.0 Hz, 1 H); 13C NMR (100 MHz, D2O): δ = 29.0 (d, J = 8.8 Hz), 30.4 (d, J = 3.6 Hz), 34.2 (d, J = 13.0 Hz), 34.3 (d, J = 132.6 Hz), 44.3, 59.2, 174.3; 31P NMR (162 MHz, D2O): δ = 23.2; HRMS (ESI+): m/z [M + Na+] calcd for C7H14NO5PNa: 246.0502; found: 246.0501; Anal. Calcd for C7H14NO5P: C, 37.67; H, 6.32; N, 6.28. Found: C, 37.58; H, 6.37; N, 6.23.
<A NAME="RD15606ST-18">18</A>
Martin I.
Anvelt J.
Vares L.
Kühn I.
Claesson A.
Acta Chem. Scand.
1995,
49:
230
<A NAME="RD15606ST-19">19</A>
Carey FA.
Sundberg RJ.
Advanced Organic Chemistry: Structure and Mechanisms, Part A
4th ed.:
Springer Science;
New York:
2000.
<A NAME="RD15606ST-20">20</A>
Badorrey R.
Cativiela C.
Díaz-de-Villegas MD.
Gálvez JA.
Tetrahedron
2002,
58:
341
<A NAME="RD15606ST-21">21</A>
(2
R
,4
R
)-2-[(
S
)-1,2-Dibenzyloxyethyl]-4-diethylphos-phonomethyl-1-[(
S
)-1-phenylethyl]piperidine (9). A 0.1 M solution of L-Selectride® in THF (4 mL, 4 mmol) was added drop wise to an E/Z mixture (84:16) of 5 (0.58 g, 1 mmol) dissolved in anhydrous THF (23 mL) at -20 °C under argon and the mixture was stirred
for 48 h at -20 °C. The reaction mixture was allowed to warm to 0 °C and then sat.
aq NH4Cl (8.6 mL) was added carefully with stirring. After extraction with Et2O (3 × 50 mL), the combined organic layers were dried over anhydrous MgSO4 and the solvent evaporated in vacuo to afford a crude product in which the cis diastereoisomer 6 was not detected. The residue was purified by silica gel flash column chromatography
(EtOAc ® EtOAc-EtOH, 4:1) to give 9 (412 mg, 70%) as an oil. [α]D
25 -20.1 (c 1.51, CHCl3); IR (neat): 1242 cm-1; 1H NMR (400 MHz, CDCl3): δ = 1.24 (t, J = 7.1 Hz, 6 H), 1.25 (t, J = 6.6 Hz, 3 H), 1.23-1.27 (m, 1 H), 1.49-1.55 (m, 1 H), 1.54-1.70 (m, 4 H), 2.03-2.15
(m, 1 H), 2.50-2.62 (m, 2 H), 3.15-3.21 (m, 1 H), 3.58 (dd, J = 10.7, 5.6 Hz, 1 H), 3.73 (dd, J = 10.7, 2.2 Hz, 1 H), 3.96-4.06 (m, 6 H), 4.47 (d, J = 12.5 Hz, 1 H), 4.50 (d, J = 12.5 Hz, 1 H), 4.61 (d, J = 11.7 Hz, 1 H), 4.76 (d, J = 11.7 Hz, 1 H), 7.11-7.39 (m, 15 H); 13C NMR (100 MHz, CDCl3): δ = 16.4 (d, J = 6.0 Hz), 19.0, 27.0 (d, J = 4.0 Hz), 31.3 (d, J = 7.7 Hz), 31.9 (d, J = 140.2 Hz), 33.0 (d, J = 11.5 Hz), 42.3, 54.1, 59.1, 61.2 (d, J = 6.1 Hz), 61.3 (d, J = 6.0 Hz), 71.5, 72.7, 73.3, 78.2, 126.4, 127.2, 127.3, 127.4, 127.5, 127.7, 128.0,
128.2, 128.3, 138.5, 139.1, 146.9; 31P NMR (162 MHz, CDCl3): δ = 31.8; HRMS (ESI+): m/z [M + H+] calcd for C34H47NO5P: 580.3186; found: 580.3174.
<A NAME="RD15606ST-22">22</A>
(2
R
,4
R
)-1-
tert
-Butoxycarbonyl-4-diethylphosphono-methyl-2-[(
S
)-1,2-dihydroxyethyl]piperidine (10). Chromatography eluent: EtOAc-EtOH, 4:1; yield 76%; oil, [α]D
25 +37.9 (c 0.80, CHCl3); IR (neat): 3414, 1683, 1252 cm-1; 1H NMR (400 MHz, CDCl3): δ = 1.04-1.17 (m, 1 H), 1.26 (t, J = 7.1 Hz, 6 H), 1.28-1.35 (m, 1 H), 1.39 (s, 9 H), 1.48-1.67 (m, 2 H), 1.76 (br d,
J = 12.7 Hz, 1 H), 1.91 (br d, J = 12.7 Hz, 1 H), 2.05-2.23 (m, 1 H), 3.03 (br dd, J = 12.6, 12.6 Hz, 1 H), 3.48 (dd, J = 11.1, 4.3 Hz, 1 H), 3.59 (dd, J = 11.1, 2.6 Hz, 1 H), 3.83-3.90 (m, 1 H), 3.88-3.97 (m, 1 H), 4.02 (q, J = 7.1 Hz, 4 H), 4.24-4.32 (m, 1 H); 13C NMR (100 MHz, CDCl3): δ = 16.3 (d, J = 6.0 Hz), 26.6 (d, J = 3.1 Hz), 28.3, 32.7 (d, J = 139.3 Hz), 33.1 (d, J = 12.2 Hz), 34.3 (d, J = 9.9 Hz), 40.7, 50.8, 61.5 (d, J = 1.9 Hz), 61.6 (d, J = 1.9 Hz), 64.0, 72.5, 80.0, 156.5; 31P NMR (162 MHz, CDCl3): δ = 30.9; HRMS (ESI+): m/z [M + Na+] calcd for C17H34NO7PNa: 418.1965; found: 418.1976.
<A NAME="RD15606ST-23">23</A>
(2
R
,4
R
)-1-
tert
-Butoxycarbonyl-4-diethylphosphono-methylpipecolic Acid (11). Yield 73%; oil, [α]D
25 +13.0 (c 1.09, CHCl3); IR (neat): 3700-2300, 1732, 1699, 1251 cm-1; 1H NMR (mixture of conformers) (400 MHz, CDCl3): δ = 1.07-1.22 (m, 1 H), 1.31 (t, J = 7.0 Hz, 3 H), 1.31 (t, J = 7.1 Hz, 3 H), 1.32-1.50 (m, 1 H), 1.42 and 1.45 (s, 9 H), 1.60-1.79 (m, 2 H), 1.82-1.95
(m, 2 H), 2.38-2.46 (m, 1 H), 2.98 and 3.07 (ddd, J = 12.9, 12.9, 1.3 Hz and J = 13.0, 13.0, 1.5 Hz, 1 H), 3.94 and 4.00-4.07 (br dd, J = 13.0, 1.3 Hz and m, 1 H), 4.09 (q, J = 7.1 Hz, 4 H), 4.71-4.76 and 4.92-4.96 (m, 1 H); 13C NMR (mixture of conformers) (100 MHz, CDCl3): δ = 16.3 (d, J = 6.1 Hz), 27.6 (d, J = 3.3 Hz) and 27.7 (d, J = 3.4 Hz), 28.2 and 28.3, 32.0 (d, J = 140.0 Hz) and 32.1 (d, J = 139.9 Hz), 32.3 (d, J = 10.9 Hz) and 32.4 (d, J = 9.3 Hz), 34.2 (d, J = 13.0 Hz), 40.5 and 41.5, 53.5 and 54.6, 61.8 (d, J = 6.7 Hz), 61.9 (d, J = 6.5 Hz), 79.9 and 80.1, 155.3 and 155.9, 172.9 and 173.5; 31P NMR (mixture of conformers) (162 MHz, CDCl3): δ = 31.3 and 31.5; HRMS (ESI+): m/z [M + Na+] calcd for C16H30NO7PNa: 402.1652; found: 402.1651.
<A NAME="RD15606ST-24">24</A>
(2
R
,4
R
)-4-Phosphonomethylpipecolic Acid (2). Yield 74%; white solid, mp (dec) = 158-160 °C; [α]D
25 -25.3 (c 0.69, H2O); IR (KBr): 3780-2200, 3435, 1730, 1262 cm-1; 1H NMR (400 MHz, D2O): δ = 1.56-1.67 (m, 1 H), 1.77 (dd, J = 18.5, 6.7 Hz, 2 H), 1.92 (ddd, J = 13.5, 8.1, 4.7 Hz, 1 H), 1.95-2.04 (m, 1 H), 2.03-2.14 (m, 1 H), 2.26 (ddd, J = 13.5, 6.3, 3.4 Hz, 1 H), 3.28 (dd, J = 13.2, 6.6 Hz, 1 H), 3.33 (dd, J = 13.2, 4.2 Hz, 1 H), 4.06 (dd, J = 6.3, 4.7 Hz, 1 H); 13C NMR (100 MHz, D2O): δ = 26.1 (d, J = 3.1 Hz), 27.8 (d, J = 9.4 Hz), 31.2 (d, J = 11.6 Hz), 31.2 (d, J = 134.3 Hz), 40.5, 53.9, 171.7; 31P NMR (162 MHz, D2O): δ = 24.6; HRMS (ESI+): m/z [M + Na+] calcd for C7H14NO5PNa: 246.0502; found: 246.0494; Anal. Calcd for C7H14NO5P: C, 37.67; H, 6.32; N, 6.28. Found: C, 37.56; H, 6.24; N, 6.33.